The implementation of standardized protocols and a multidisciplinary approach improved reporting; discrepancies in disease classification and the amount of missing data were reduced; and quality measures and prognostic capabilities of the team were substantially improved. Such established data-driven practice supports faster decision making to enucleate diseased eyes and save patients' lives through providing measurable indicators.
Objectives:The aim of this study was to determine the prevalence of visual impairment and percent distribution of childhood diseases affecting vision among preschool children (one day to 6 years) in Giza governorates of Egypt as a first step in National survey.Methods: A population-based survey was conducted on a multistage cluster sampling. Target population was one day to 6 years children living in rural areas of Giza, governorate using systematic random samples based on birth records. The total sample of children includes 4470 preschool children; 2304 males and 2166 females. They are socio-demographically surveyed for their living condition.
Results:The total number of children subjected for ophthalmologic examination, visual assessment, genetic and pediatric examination were 2603 child. About 40% of them were diagnosed to have different eye problems. About 7.4% of examined children were diagnosed to have different genetic problems.
Conclusion:This survey could be considered as the first building block of Egyptian health map by providing a baseline data on childhood blindness helping Egyptian health community direct their health services towards the actual needs present in the community.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.